Acetaminophen interactions with immune checkpoint inhibitors: guilt by association?
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: cancer, it is important to carefully evaluate the clinical significance of these findings
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Using the WHO Causality Assessment and the Drug Interaction Probability Score to evaluate the available evidence, however, it seems unlikely or doubtful that there is a clinically significant interaction between acetaminophen and immune ch…
Recent studies suggest that acetaminophen may be linked to poorer long-term outcomes in patients receiving immune checkpoint inhibitors.
APA
de Lemos ML, de Lemos J, et al. (2025). Acetaminophen interactions with immune checkpoint inhibitors: guilt by association?. Journal for immunotherapy of cancer, 13(10). https://doi.org/10.1136/jitc-2025-012355
MLA
de Lemos ML, et al.. "Acetaminophen interactions with immune checkpoint inhibitors: guilt by association?." Journal for immunotherapy of cancer, vol. 13, no. 10, 2025.
PMID
41161820 ↗
Abstract 한글 요약
Recent studies suggest that acetaminophen may be linked to poorer long-term outcomes in patients receiving immune checkpoint inhibitors. Since acetaminophen is a widely used and essential medication for many patients with cancer, it is important to carefully evaluate the clinical significance of these findings. Using the WHO Causality Assessment and the Drug Interaction Probability Score to evaluate the available evidence, however, it seems unlikely or doubtful that there is a clinically significant interaction between acetaminophen and immune checkpoint inhibitor. We recommend that acetaminophen should not be restricted when used with checkpoint inhibitors until more robust evidence is available.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.